RecruitingNot applicableNCT06909799

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Aurum Institute NPC
Principal Investigator
Robert Wallis - Professor
Aurum Institute
Intervention
N-Acetyl Cysteine (NAC)(drug)
Enrollment
242 target
Eligibility
18-65 years · All sexes
Timeline
2025 – 2027

Study locations (1)

Collaborators

Ludwig-Maximilians - University of Munich · Research Center Borstel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06909799 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials